|Agreement labeling||Elsevier Read & Publish|
|Has the agreement been disclosed and published?||Yes
|Agreement period||01/01/2020 – 12/31/2022|
|Consortia / Institution||Bibsam Consortium|
Approximate range of annual corresponding author publications
|Comments on size/article output||List of titles that allow publishing will change throughout the agreement period|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of oa publishing entitlements?
|Unlimited publishing in Science Direct and gold journals. Limited publishing allowed in Cell Press hybrid titles, but the number or articles is expected to cover the consortium output.|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for oa publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY preference, exceptions allowed|
||Original research articles
Data in brief, Full-length article, Insights, Micro-article, Original software publication, Protocols, Review article, Short communication, Short review, Video Article
What is the approximate share of access related costs of the overall agreement?
|Comments on access costs||Very approximate share. Access related cost not entirely possible to separate from publishing cost.|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||No|
|Comments on workflows||Articles covered from submission date (not acceptance date)|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|